Skystar Bio-pharmaceutical Co (SKBI) Financial Statements (2024 and earlier)

Company Profile

Business Address RM 10601, JIEZUO PLAZA, NO. 4
XIAN PROVINCE, 00000
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments16,4216,8498,1424,4576,3123,979
Cash and cash equivalents16,4216,8498,1424,4576,3123,979
Restricted cash and investments7,150     
Receivables25,73519,11411,00926,90112,12712,529
Inventory, net of allowances, customer advances and progress billings23,82625,26625,90427,40826,50023,651
Inventory23,82625,26625,90427,40826,50023,651
Prepaid expense2,0101,6082,1341,7832,543 
Advances on inventory purchases38,40840,54141,06127,67132,36033,285
Deposits current assets488487491489527 
Prepaid expense and other current assets2,546
Deferred tax assets375403364344  
Other undisclosed current assets(7,270)(5,890)(491)(429)(446) 
Total current assets:107,14288,37888,61588,62479,92475,991
Noncurrent Assets
Property, plant and equipment29,98430,41828,26928,57328,84928,733
Intangible assets, net (including goodwill)5,0755,1305,2375,2775,3075,289
Intangible assets, net (excluding goodwill)5,0755,1305,2375,2775,3075,289
Prepaid expense4,5984,5934,6344,6221,072 
Prepaid expense and other noncurrent assets1,056
Other undisclosed noncurrent assets(26,734)(30,418)(28,086)(28,390)(28,667)(28,554)
Total noncurrent assets:12,9239,72310,05410,0826,5606,524
Other undisclosed assets36,50036,88837,55437,67937,88737,474
TOTAL ASSETS:156,565134,990136,223136,385124,372119,988
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10,7157,6324,8338,8242,9316,738
Taxes payable4,2412,8531,3154,9731,3791,673
Accounts payable6,4474,6163,3043,7621,5525,065
Accrued liabilities 2716321488  
Debt118,0005,68110,64110,59510,5306,863
Due to related parties3,3291,9621,3621,7421,1081,002
Customer advances and deposits1,894 
Other undisclosed current liabilities(91,672)8,3808,1317,2286,4615,560
Total current liabilities:42,26723,65524,96628,38821,03120,163
Noncurrent Liabilities
Liabilities, other than long-term debt7968748651,0045991,070
Deferred revenue and credits7967958027995991,069
Derivative instruments and hedges, liabilities  7962206 1
Other undisclosed noncurrent liabilities      1,277
Total noncurrent liabilities:7968748651,0045992,347
Total liabilities:43,06324,52925,83029,39321,63022,510
Equity
Equity, attributable to parent, including:113,502110,461110,393106,992102,74297,479
Preferred stock      
Common stock888888
Additional paid in capital37,78637,69137,63137,02437,02137,021
Accumulated other comprehensive income10,97910,84411,81111,35010,8379,325
Retained earnings58,77655,96654,99052,71348,97945,228
Other undisclosed equity, attributable to parent5,9535,9535,9535,8975,8975,897
Total equity:113,502110,461110,393106,992102,74297,479
TOTAL LIABILITIES AND EQUITY:156,565134,990136,223136,385124,372119,988

Income Statement (P&L) ($ in thousands)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Revenues14,2506,8339,62515,99211,3355,531
Revenue, net14,2406,8339,62515,99211,3355,531
Cost of revenue
(Cost of Goods and Services Sold)
(8,415)(4,201)(5,245)(8,584)(5,821)(3,135)
Other undisclosed gross profit523192339805444204
Gross profit:6,3592,8234,7208,2145,9572,600
Operating expenses(2,991)(1,651)(2,061)(3,476)(1,411)(1,530)
Operating income:3,3681,1722,6594,7384,5461,070
Nonoperating income (expense)125233275(222)(99)(36)
Investment income, nonoperating 79(17)143(204)1534
Other nonoperating income (expense)191551933(4)(0)
Interest and debt expense(174)     
Income from continuing operations before equity method investments, income taxes:3,3191,4052,9344,5164,4481,034
Other undisclosed income from continuing operations before income taxes174     
Income from continuing operations before income taxes:3,4931,4052,9344,5164,4481,034
Income tax expense(682)(430)(601)(782)(697)(321)
Income from continuing operations:2,8119752,3323,7343,751713
Income before gain (loss) on sale of properties:2,8119752,3323,7343,751713
Net income available to common stockholders, diluted:2,8119752,3323,7343,751713

Comprehensive Income ($ in thousands)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Net income:2,8119752,3323,7343,751713
Comprehensive income:2,8119752,3323,7343,751713
Other undisclosed comprehensive income (loss), net of tax, attributable to parent135(967)4615131,512551
Comprehensive income, net of tax, attributable to parent:2,94692,7944,2475,2631,264

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: